Radiation exposure of the investigator's hand during fusion imaging of the thyroid with 99mTcO4-free-hand SPECT and ultrasound

67 Ga-PSMA I&T for Radioguided Surgery of Lymph Node Metastases in Patients With Biochemical Recurrence of Prostate Cancer

PURPOSE

Radioguided lymph node dissection in patients with prostate cancer, and suffering from biochemical recurrence has been described thoroughly during the past few years. Several prostate-specific membrane antigen (PSMA)-directed ligands labeled with 111 In, 99m Tc, and 68 Ga have been published; however, limitations regarding availability, short half-life, high costs, and unfavorable high energy might restrict frequent use. This study aims at introducing 67 Ga as a promising radionuclide for radioguided surgery.

METHODS

Retrospective analysis was performed on 6 patients with 7 PSMA-positive lymph node metastases. 67 Ga-PSMA I&T (imaging and therapy) was synthesized in-house and intravenously applied according to §13 2b of the German Medicinal Products Act. Radioguided surgery was performed 24 hours after injection of 67 Ga-PSMA I&T using a gamma probe. Patient urine samples were collected. Occupational and waste dosimetry was performed to describe hazards arising from radiation.

RESULTS

67 Ga-PSMA application was tolerated without adverse effects. Five of 7 lymph nodes were detected on 22-hour SPECT/CT in 4 of 6 patients. During surgery, all 7 lymph node metastases were identified by positive gamma probe signal. Relevant accumulation of 67 Ga was observed in lymph node metastases (32.1 ± 15.1 kBq). Histology analysis of near-field lymph node dissection revealed more lymph node metastases than PET/CT (and gamma probe measurements) identified. Waste produced during inpatient stay required decay time of up to 11 days before reaching exemption limits according to German regulations.

CONCLUSIONS

Radioguided surgery using 67 Ga-PSMA I&T is a safe and feasible option for patients suffering from biochemical recurrence of prostate cancer. 67 Ga-PSMA I&T was successfully synthesized according to Good Manufacturing Practice guidelines. Radioguided surgery with 67 Ga-PSMA I&T does not lead to relevant radiation burden to urology surgeons and represents a novel interdisciplinary approach in nuclear medicine and urology.

Feasibility and Performance of Free-Hand Single-Photon Computed Tomography/Ultrasonography for Preoperative Parathyroid Adenoma Localization: A Pilot Study

The aim of this prospective pilot study was to evaluate the feasibility of a new hybrid imaging modality, free-hand single-photon computed tomography/ultrasonography (fhSPECT/US), for preoperative localization of parathyroid adenomas and to compare its performance with conventional ultrasonography and SPECT/CT. Twelve patients diagnosed with primary hyperparathyroidism underwent sequentially US and parathyroid scintigraphy, including SPECT/CT, followed by fhSPECT/US, allowing for real-time fusion between US and freehand-generated gamma-camera images. The fhSPECT/US detection rates were correlated with histopathology, when available, or with the imaging modality showing the most lesions. Based on a per patient analysis, the detection rate was significantly different when comparing SPECT/CT to fhSPECT/US (p = 0.03), and not significantly different when comparing SPECT/CT to US (p = 0.16) and US to fhSPECT/US (p = 0.08). Based on a per-lesion analysis, the detection rate of SPECT/CT was significantly higher than that of US (p = 0.01) and fhSEPCT/US (p = 0.003), and there was no significant difference in detection rate when comparing US to fhSPECT/US (p = 0.08). The main perceived limitations of fhSPECT/US in lesion detection were: (i) lesions localized at a depth ≥4.5 cm; (ii) imperfect image fusion due to tissue compression; (iii) limited spatial manipulation ability of the SPECT mobile camera handheld probe; and (iv) a wide spread of detected activity. In conclusion, clinical use of fhSPECT/US for localization of parathyroid adenomas is feasible, but shows lower sensitivity than conventional modalities and requires technical improvements.

Renal scintigraphy to predict persistent renal failure after acute kidney injury: an observational study

INTRODUCTION

Renal scintigraphy (RS) is occasionally performed to assess the risk of persistent renal failure (PRF) in patients with acute kidney disease (AKD). However, its diagnostic performance has never been assessed.

METHODS

We identified all patients with AKD for whom RS was performed in our institution between 2010 and 2017. PRF was defined as persistently low (< 33% of baseline) estimated glomerular filtration rates (eGFR), 1 year after RS. Nuclear medicine specialists reviewed RS data and rated, for each patient, the likelihood of PRF ("PRF score"). We evaluated the performance to predict PRF (area under the ROC curve (AUC)) of RS-derived parameters such as renal accumulation index, accumulation slope, and new parameters derived from serial kidney activity counts. We tested the ability of those parameters to improve a clinical model including hypertension, diabetes, AKI severity and baseline eGFR. Finally, we conducted sensitivity analyses using alternate PRF definitions.

RESULTS

Among 97 patients included, 57 (59%) fulfilled the criteria for PRF. The PRF score was able to predict PRF with an AUC of 0.63. Similarly, the accumulation index and accumulation slope respective AUCs were 0.64 and 0.63. None of these parameters were able to improve the performance of the clinical model. Among new parameters, the 3rd/2nd minute activity ratio and 3rd/2nd minute activity slope had fair diagnostic performance (AUC 0.72 and 0.74, respectively) and improved the performance of the clinical model. Results were confirmed in sensitivity analyses.

CONCLUSION

Conventional renal scintigraphy can identify patients at high risk of PRF with a high specificity but a low sensitivity. New parameters, with comparable diagnostic abilities can be obtained within three minutes of injection.

RADIATION EXPOSURE OF THE INVESTIGATOR DURING NAVIGATED FUSION OF 124IODINE PET IMAGING AND ULTRASOUND

To assess the radiation exposure of the investigator during navigated fusion of nuclear medicine images with ultrasound after application of I-124. Dosimetry with two different types of thermoluminescent detectors (TLD) was performed in 25 patients. The dose rate at the patient's neck was measured with a calibrated dose rate meter (DRM) and served as the standard of reference. The average exposure per investigation at the patient's neck measured by LiF:Mg,Cu,P TLDs (cumulative: 212 μSv), LiF:Mg,Ti TLDs (cumulative: 112 μSv) and DRM (cumulative: 150.3 μSv). The radiation exposure of the hand during navigated fusion of nuclear medicine imaging with 124I and ultrasound with a mean duration of 13 min is low and comparable between different methods. Yearly examinations are not expected to add a relevant cumulative risk.

Comparison with adsorption of Re (VII) by two different γ-radiation synthesized silica-grafting of vinylimidazole/4-vinylpyridine adsorbents

Two silica gel based adsorbents for Re (VII), i.e. SS-MPTS-VIMH and SS-MPTS-VPQ, were synthesised. Silica gel was used as the matrix for γ-radiation grafting, and the monomer of 1-vinyl imidazole (VIM) and 4-vinylpyridine (4-VP) was grafted onto the silica silanized by methacryloxy propyl trimethoxyl silane, respectively. A VIM concentration of 2molL^-1 and an absorbed dose of 30kGy were the optimal grafting conditions for adsorbent SS-MPTS-VIM, and a 4-VP concentration of 4molL^-1 and an absorbed dose of 40kGy were the optimal grafting conditions for adsorbent SS-MPTS-VP. At the certain condition, the grafting yield of SS-MPTS-VIM was 30.1% and that of SS-MPTS-VP was 21.0%. The adsorption capacity of adsorbent SS-MPTS-VIMH was 145.99mgg^-1 and that of SS-MPTS-VPQ was 71.08mgg^-1 according to the Langmuir model. The adsorbent SS-MPTS-VPQ had better adsorption properties of acid resistance and anti-interference than SS-MPTS-VIMH. Dynamic column experiments showed that protonated adsorbent SS-MTPS-VIMH could be recycled with good performance while quaternized adsorbent SS-MPTS-VPQ could not. The adsorbent SS-MPTS-VIMH belongs to weak anion exchange adsorbent and SS-MPTS-VPQ belongs to strong anion exchange adsorbent. This study paves a way to the synthesis and application of a novel silica base adsorbents for Re (VII).